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Background. Sepsis patients may die either from an overwhelming systemic immune response and/or from an
immunoparalysis-associated lack of anti-bacterial immune defence. We hypothesized that bacterial superantigen-activated
T cells may be prevented from contribution into anti-bacterial response due to the inhibition of their effector functions by the
hypoxia inducible transcription factor (HIF-1a) in inflamed and hypoxic areas. Methodology/Principal Findings. Using the
Cre-lox-P-system we generated mice with a T–cell targeted deletion of the HIF-1a gene and analysed them in an in vivo model
of bacterial sepsis. We show that deletion of the HIF-1a gene leads to higher levels of pro-inflammatory cytokines, stronger
anti-bacterial effects and much better survival of mice. These effects can be at least partially explained by significantly
increased NF-kB activation in TCR activated HIF-1 a deficient T cells. Conclusions/Significance. T cells can be recruited to
powerfully contribute to anti-bacterial response if they are relieved from inhibition by HIF-1a in inflamed and hypoxic areas.
Our experiments uncovered the before unappreciated reserve of anti-bacterial capacity of T cells and suggest novel
therapeutic anti-pathogen strategies based on targeted deletion or inhibition of HIF-1 a in T cells.
Citation: Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, et al (2007) Targeted Deletion of HIF-1a Gene in T Cells Prevents their Inhibition in Hypoxic
Inflamed Tissues and Improves Septic Mice Survival. PLoS ONE 2(9): e853. doi:10.1371/journal.pone.0000853
INTRODUCTION
The surprisingly low incidence of serious complications after
normal immune response to pathogens suggests the functioning of
regulatory mechanisms that limit the collateral inflammatory
damage to normal cells. It was suggested that it is the damage to
the microvasculature and the ensuing decrease in oxygen supply
(local tissue hypoxia) that may serve as primary signals of excessive
tissue damage and need to de-activate immune cells [1]. One of
the hypoxia-generated signals of excessive inflammation could be
the accumulation of extracellular adenosine [2], while the second
signal could be provided by a hypoxia-sensing molecule [1]. It was
proposed that the overactive T-cells in inflamed and hypoxic areas
are down-regulated by A2A adenosine receptors [1] and hypoxia
inducible factor 1a (HIF-1a) [3,4] which may act in concert [5,6].
While the genetic evidence for the critical role of A2A adenosine
receptors in down-regulation of activated immune cells in vivo has
been provided using A2A receptor deficient mice [2,6], thereby
confirming the overall validity of this ‘‘anti-inflammatory hypoxia’’
hypotheses, the anti-inflammatory role of HIF-1a in T cells in vivo
remained to be proven using appropriate genetic models. The
hypothesis of HIF-1a being anti-inflammatory in T cells seems to be
counter-intuitive, since the myeloid cell-targeted deletion of HIF-
1a resulted in the loss of inflammatory response by myeloid cells
leading to the impression that HIF-1a in myeloid cells is pro-
inflammatory [7]. Despite these findings, we reasoned that T cells
may be different from macrophages and neutrophils, which are
known to be much more dependent on glycolysis-derived ATP and
therefore on glycolysis-controlling HIF-1a- [7]. We considered
that since HIF-1a is not as critical for activated T cells’ short term
survival as it is for myeloid cells, it may play an important T cell-
down regulating role in inflamed and hypoxic tissue microenviron-
ments in vivo by acting in concert with other hypoxia-triggered
mechanisms [1,5]. To directly test this we used mice with T cell
targeted deletion of HIF-1a gene. The present studies of bacterial
sepsis show that T–cell specific deletion of HIF-1 a in mice results
in: i) higher levels of pro-inflammatory cytokines; ii) stronger anti-
bacterial effects of T cells and granulocytes and iii) better survival
of mice from cecal ligation and puncture (CLP)-induced bacterial
sepsis [8]. In vitro studies to clarify the possible mechanism of the in
vivo observations revealed much faster cell proliferation and
enhanced activation of NF-kB in HIF-1a deficient T cells.
Quantitative real-time RT-PCR showed higher NF-kB p50
subunit expression in TCR stimulated T cells upon HIF-1a
deletion, suggesting that the HIF-1a-mediated pathway is at least
in part responsible for the suppression of NF-kB dependent cell
proliferation and pro-inflammatory cytokine production. These
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experiments uncover the before unappreciated reserve of pro-
inflammatory capacity of T cells in vivo and suggest novel
therapeutic strategies when there is a need to enhance activity of
T cells in hypoxic and/or inflamed tissues. We propose to inhibit
HIF-1a in order to relieve from inhibition the ‘‘anti-bacterial’’ T
cells during immune response to drug-resistant bacteria.
RESULTS AND DISCUSSION
T-cells are present in hypoxic inflamed peritoneum
but do not seem to contribute to anti-bacterial
immune response
The comparison of survival rates of WT (n= 10) vs. T cell deficient
RAG-2 knockout (n = 10) mice revealed no differences suggesting
that T cells do not contribute to an anti-sepsis immune response in
our model of sepsis (data not shown). We tested whether this could
be explained by i ) the lack of T cells’ presence in hypoxic inflamed
areas or ii) by hypoxic inhibition of activated T cells in the local
inflamed microenvironment.
The use of the in vivo hypoxic marker EF5 [9] allowed to
discount the possibility of T cells avoiding hypoxic areas in order
to maintain the highest levels of activation [10]. The labelling of
both CD4+ and CD8+ peritoneal T cells in vivo by EF5 is
diagnostic of their exposure to a less than 1% oxygen tension [9] in
inflamed areas of the peritoneum (Fig. 1A).
To test whether the failure to observe T cells’ contribution in
anti-bacterial response and pathogen destruction was due to their
negative regulation by hypoxia-stabilized and TCR-activation
induced HIF-1a, we studied newly developed mice with T cell
targeted deletion of the HIF-1 a gene. We hypothesized that if
HIF-1a was indeed one of the mediators of immunosuppressive
effects of hypoxia [10] by inhibiting T cells, then it would be
expected that HIF-1a gene-deficient T cells would be resistant to
inhibition in inflamed and hypoxic areas of peritoneum. This, in
turn, would be expected to result in uninhibited production of e.g.
Figure 1. Increased survival and decreased bacterial sepsis-associated tissue damage of mice with T-cell targeted deletion of HIF-1a. A: Use of
the hypoxic marker EF5 reveals that CD4+ and CD8+ T cells have been exposed to low oxygen tension (hypoxic) conditions in the peritoneum during sepsis
in mice. Single cell suspensions from peritoneal lavage fluid and spleens were analyzed by flow cytometry using anti-EF5 mAb (Elk3-52 Cy5). B: High
Efficiency of Cre recombinase-mediated deletion of HIF-1 a in T-Cells. Efficiency of deletion was calculated by quantitative real-time PCR as described.
Constitutively synthesized HIF-1 a mRNA was detected in control (lck-Cre negative) but not in (lck-Cre positive) HIF1 a gene targeted mice. N= 3 per
group. C: T cell lineage specific HIF-1 a deficient mice are more resistant to lethal sepsis after cecal ligation and puncture procedure. Mice underwent CLP
and were observed for mortality. N = 13 per group. p = 0.0326, Logrank (Mantel-Cox). D: T cell lineage specific HIF-1 a deficient mice have less sepsis-
associated liver damage as evaluated by levels of ALT transaminase activity in serum. Serum samples obtained from mice 72 hrs after CLP. *:p,0.05 vs.
WT, N= 5–6 per group.
doi:10.1371/journal.pone.0000853.g001
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IFN-c and of other pathogen-destroying cytokines by activated T
cells, as well as in the overall enhancement of the anti-bacterial
host response and better survival.
Selective disruption of HIF-1 a in T cells rescues mice
from septic death and decreases bacterial burden-
associated tissue damage
The possible contribution of T cells may have been overlooked in
models of sepsis with early (,24 hour) lethal outcomes, since T
cells may require longer than 24 hrs to be recruited to and
activated in inflamed environment. Therefore, we have adapted
a more long-lasting model of sepsis with ,50% mortality after
72 hours of CLP [8] to allow sufficient time for T cell recruitment
and activation in inflamed peritoneum so that T cells will have an
opportunity to contribute to the anti-bacterial response. Compar-
ative studies of mice with the confirmed HIF-1 a deletion in their
T cells (Fig. 1B) supported the view that HIF-1a in T cells did
inhibit them during sepsis. This was reflected in a statistically
significant increase in survival of mice with HIF-1a-deficient T
cells as compared with their HIF-1 a expressing littermates
(Fig. 1C). Survival between lck-Cre (+) and lck-Cre (2) control
mice was not different, demonstrating that the difference in
survival between lck-Cre (+) HIF-1 a loxP and lck-Cre (2) HIF-1
a loxP mice was indeed due to Cre mediated HIF-1 a knock-down
(data not shown). In another control, the sham CLP surgery did
not result in any mouse mortality (data not shown).
The significantly higher survival rates of mice with T cell-
targeted deletion of HIF-1 a gene (n= 27) as compared with
control HIF-1 a expressing mice (n = 29) were also observed in
other independent experiments in different mice facilities
(p = 0.040, log rank test; C. Caldwell, data not shown).
The HIF-1 a deficient mice also had much less sepsis-associated
tissue damage in different organs as demonstrated by an e.g.
significant decrease in levels of liver enzymes (Fig. 1D).
Histological analysis of livers revealed less apoptotic hepatocytes
72 hrs after CLP in HIF-1 a deficient mice (not shown).
The protective effects of genetic inactivation of HIF-1a in T
cells are most likely due to the relief from the negative regulation
by HIF-1a of pro-inflammatory, anti-bacterial functions of T cells.
This is reflected in the strong attenuation of bacterial burden in
spleen and liver of HIF-1 a-deleted mice (Fig. 2A). The
quantitative data showing that the decrease in bacterial counts
are paralleled by a dramatic decrease in the number of gas-
forming bacteria in HIF-1 a-deficient mice. For instance, Fig. 2B
shows that masses of gas-forming bacteria formed rings around gas
Figure 2. Decreased bacterial burden in mice with T-cell targeted deletion of HIF-1 a. A: T cell lineage specific HIF-1 a deficient mice have much less
bacterial burden in liver and spleen 72 hrs after CLP *:p,0.05 vs. WT, means6SEM, N= 3 per group. B: Growth of gas-forming bacteria and tissue
destruction during CLP-induced sepsis in mice with HIF-1 a-expressing T cells, but not in mice with HIF-1 a gene–deleted T cells. Masses of bacteria form
rings around gas bubbles in spleens of mice with HIF-1 a expressing T cells. Much less bacteria could be seen in the spleen taken 72 h after CLP from
mice with HIF-1 a deficiency in T cells. C: T-cell specific deficiency in HIF-1 a enhances effector functions of bactericidal granulocytes. Left Panel: Much
stronger upregulation of activation marker CD11b on tissue granulocytes (CD11b+/Gr-1bright cells) isolated from HIF-1 a-deleted mice compared to
HIF-1 a -expressing control mice. *:p,0.05 vs. WT, N= 3. Right Panel: Higher spontaneous production of hydrogen peroxide by tissue granulocytes
(CD11b+/Gr-1bright cells) in HIF-1 a-deleted mice than in HIF-1 a-expressing control mice. *:p,0.05 vs. WT, N= 3.
doi:10.1371/journal.pone.0000853.g002
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bubbles that also contained free bacteria in the spleen of HIF-1 a-
expressing mice. Such intensive bacterial growth was not observed
in littermates with HIF-1 a-deficient T cells. These data provide
direct microbiological and histological evidence that HIF-1
a inhibits anti-bacterial activities of T cells (Fig. 2A,B). In-
activation of HIF-1 a in T cells might contribute to amplification
of bactericidal functions of cells of the innate immune system.
Accordingly, granulocytes isolated from septic mice with T cell
specific HIF-1 a deficiency were much stronger activated as
indicated by levels of CD11b cell surface expression and H2O2
production (Fig. 2C). In agreement with the general view that
IFN- c is a likely candidate for T cell dependent enhancement of
bactericidal functions of granulocytes, the observed rescue from
septic death and the decrease in the bacteria-mediated tissue
damage (Fig. 1C and 2A,B) in mice with HIF-1 a protein
deficiency in T cells suggested to test for a possible HIF-1a
deficiency-induced ‘‘de-inhibition’’ of secretion of pro-inflamma-
tory cytokines in TCR-activated T cells.
T cell specific deletion of HIF-1 a gene ‘‘de-inhibits’’
TCR-activated T cells and results in increased cell
proliferation and cytokines secretion
Genetic deletion of HIF-1a in T cells resulted in increased TCR
triggered cell proliferation as shown by significantly higher
percentages of cells which had undergone three or four cell
divisions upon anti-CD3 mediated activation (Fig. 3A). Although
enhanced cell proliferation may result from direct relief of cell
cycle arrest as induced by loss of HIF-1a e.g. in B cells [11], the
increase in IL-2 production we found in HIF-1a deficient T cells
might account for enhanced T cell proliferation as well (Fig. 3B).
Besides IL-2, IFN-c secretion was significantly increased with the
Figure 3. HIF-1a is a negative regulator of TCR-triggered pro-inflammatory cytokine secretion in vitro and in vivo. A: T lymphocytes deficient in
HIF-1a undergo more cell divisions as compared to wild type T cells. Splenic T cells were purified, stained using CFSE, activated for 72 hours and
analyzed by flow cytometry as described. A representative dot plot of wild type CD4 T cells (A) and HIF-1a deficient T cells (B) showing both activation
by CD25 expression and cell divisions. (C) Comparison of number of divisions by CD4 T cells.*: p,0.05 vs. WT, N= 3 per group. B: T cell specific
disruption of HIF-1 a gene substantially increases pro-inflammatory cytokine secretion by ex vivo TCR-activated T cells. Spleen T cells were derived from T
cell lineage specific HIF-1 a deficient mice. Cells were activated for 24 h under hypoxic conditions (1% O2). Extracellularly secreted cytokines were
determined by ELISA. *:p,0.05 vs. WT, N = 5. C: Higher intracellular levels of IFN-c production by inflamed peritoneum-located hypoxic HIF-1 a deficient
CD8+ T cells as compared with similarly located in vivo hypoxic HIF-1 a expressing T cells after CLP. Peritoneal lavage was performed 72 hrs after CLP and
1,56106 T cells were restimulated and stained with anti-IFN-c mAb. D: Levels of proinflammatory cytokines TNF-a and IL-6 are significantly higher as
compared to mice with selective disruption of HIF-1a gene in T-cells. Peritoneal fluid (TNF-a, left panel) and serum (IL-6, right panel) were withdrawn at
the indicated times after CLP and cytokines were determined by ELISA. Closed circles: HIF-1a KO, open circles: WT. *:p,0.05 vs. WT, N= 4
doi:10.1371/journal.pone.0000853.g003
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latter confirmed at the intracellular level in HIF-1a deficient
peritoneal T cells harvested 72 h after CLP (Fig. 3C). No
extracellularly secreted IFN-c could be detected in blood serum or
peritoneal lavage fluid neither of HIF-1aKO or HIF-1aWTmice.
However, in agreement with IFN-c acting as an autocrine or
paracrine biological immune response modifier which enhances
the production of other pro-inflammatory cytokines [12], levels of
TNF-a and IL-6 after cecal ligation and puncture were higher in
peritoneal lavage fluid and blood serum in HIF-1a KO than in
HIF-1a WT mice (Fig. 3D).
The here described first evidence of the enhanced in vivo pro-
inflammatory cytokine production by T cells deleted in HIF-1a by
the Cre-lox P system [13] is in agreement with in vitro assays of T
cell lines independently obtained from chimeric mice, where HIF-
1 a was genetically inactivated using RAG-2 gene blastocyst
complementation system [14,15].
Deletion of HIF-1a enhances TCR stimulated NF-kB
activation
The NF-kB transcription factors are key regulators of inflamma-
tory and immune response [16]. We hypothesized that observed
effects of HIF-1a deletion in T cells may be due to HIF-1a
affecting T cells by acting through NF-kB. Indeed, studies of
neutrophils did suggest that NF-kB could be hypoxia-regulated
and a HIF-dependent target to increase neutrophil survival [17].
Accordingly, we studied the effects of HIF-1a deletion on NF-kB
activity in T cells. As shown by EMSA, NF-kB DNA binding
activity was enhanced in nuclear extracts of TCR stimulated
HIF-1a deficient T cells (Fig. 4A). While in neutrophils NF-kB
p65 expression plays a major role in HIF-1a dependent regulation
of NF-kB activity [17], the TCR-stimulated NF-kB activation in T
cells comprises p50+RelA and p50+cRel heterodimers and p50
homodimers [18]. NF-kB family profiling (p65, p50, c-Rel, p52
and RelB ) of DNA binding activity of T cell nuclear extracts
showed that upon TCR activation the activity of both the p50 and
the p65 subunits significantly increased in HIF-1a deficient cells as
compared to T cells with intact HIF-1a genes (Fig. 4B). To find
out whether these findings are due to NF-kB transcription, we
performed quantitative RT-PCR which confirmed a significant
increase in NF-kB p50 mRNA expression in HIF-1a deficient T
cells (Fig. 4C). Thus, HIF-1a is likely to suppress TCR stimulated
T cell responses by preventing p50 transcription and thereby
inhibiting NF-kB activation. Although HIF-1a is capable to
directly inhibit transcription (e.g. CAD gene [19] or ENT gene
[20]), we were not able to identify putative HRE sites in the
promoter region of the p50 encoding gene [21] by analyses using
a hidden Markov model (HMM) algorithm. Alternatively, HIF-1a
might affect a multiplicity of yet unknown proteins or transcription
factors influencing the p50 transcription and therefore may
indirectly suppress p50 expression.
The reported here consideration and studies of an inhibitory
role of HIF-1a in regulation of activated T cells have been
prompted by several lines of earlier observations: i) hypoxia
inhibited the TCR-induced pro-inflammatory cytokine (e.g. IFN-
c) accumulation by T cells [10]; ii) the deletion of HIF-1a in T and
Figure 4. Increased NF-kB m-RNA expression and activity of ex vivo activated T cells of mice with T-cell targeted deletion of HIF-1 a. For all three
panels, T-cells from spleens were isolated from age and sex matched lck Cre (2) and lck Cre (+) HIF-1a loxP mice and stimulated as described (WT-S,
kO2S). Unstimulated cells served as controls (WT, kO). A: T cell specific disruption of HIF-1 a gene substantially increases NF-kB binding activity in ex
vivo TCR-activated T cells. Nuclear extracts were prepared from harvested cells and EMSA was conducted. The experiment was repeated and
representative data of two experiments are shown. All lanes contain hot binding probe for NF-kB. Specificity of EMSA was tested in the presence of
50 fold excess of either unlabeled probe (Con 1) or CRE specific probe (Con 2), respectively. B: T cell specific disruption of HIF-1 a gene increases NF-kB
p50 and p65 binding activity in ex vivo TCR-activated T cells. NF-kB-ELISA was conducted with nuclear extracts. *:p,0.05 vs. WT, N = 4. C: T cell specific
disruption of HIF-1 a gene increases NF-kB p50 mRNA expression in ex vivo TCR-activated T cells. RNA was prepared and subsided to quantitative RT-PCR.
*:p,0.01 vs. WT. N= 4.
doi:10.1371/journal.pone.0000853.g004
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B cells resulted in an increased tissue damage and autoimmunity
[14] and iii) the deletion of HIF-1a in T cells resulted in enhanced
activation of T cells in vitro [15].
The data presented here provide the first direct genetic evidence
for the negative regulation of T cell activities by HIF-1a in vivo.
Furthermore, we show that the observed anti-inflammatory effect
of HIF-1a during anti-bacterial response results from suppression
of T cell proliferation and pro-inflammatory cytokine production
most likely due to inhibition of NF-kB/p50 transcription and
subsequent reduction of NF-kB activity.
Of potential clinical significance, these observations offer a new
approach to enhance the immune response by de-inhibiting T cells
from HIF-1a–mediated immunosuppression and thereby enhanc-
ing production of IFN-c by T cells in vivo. This may-in turn-lead to
a greater activation of cells of the innate immune system, which
then play a key role in the early bacterial elimination. Our findings
may re-invigorate the attention to the anti-bacterial effects of
T cells and appeal to recruit T cells’ powerful, but otherwise
unavailable anti-bacterial capacity in novel anti-sepsis therapies.
Moreover, our observations of T cells inhibition by HIF-1a in
hypoxic inflamed peritoneum suggest that activated anti-tumor
T cells may be also inhibited near or within hypoxic tumors by
HIF-1a. The HIF-1a-mediated inhibition may be additive or
synergistic with immunosupression caused by tumor hypoxia-
produced extracellular adenosine that is protecting tumors by
inhibiting the incoming anti-tumor T cells via their A2A adenosine
receptors [22].
MATERIALS AND METHODS
Generation of lck-Cre+/HIF1-a loxP floxed/floxed
mice
Mice with T cell-targeted deletion of HIF-1 a gene have been
generated as described in [15]. This allows for a T cell lineage
specific HIF-1 a deletion in lck-Cre positive mice, while the lck-
Cre negative littermates are HIF-1 a positive and can be used as
controls. The gross phenotype of the lck-Cre (+) HIF-1 a loxP
mouse was not markedly different from lck Cre (2) HIF-1 a loxP
mouse (HIF-1 a expressing littermates) as judged by viability,
weight, or limb deformities.
Determination of deletion efficiency
For the measurement of deletion efficiency of HIF-1 a in lck-Cre
(+) mice the purified T cells were obtained by positive selection on
AutoMACS cell separator using anti-CD3 mAb and HIF-1
a mRNA expression was determined by real time RT-PCR as in
[23] using primers spanning the targeted region as well as primers
for an undeleted control gene for normalization.
Cecal ligation and puncture
To enable the investigation of the possible role of T cells in
clearing bacterial infections, we have adapted a murine model of
sepsis, which results in 50% mortality after 72 hours of cecal
ligation and puncture (CLP) [8]. By avoiding the early (,24 hour)
lethal events of sepsis enabled us to study the behavior of T cells,
which may have required longer than 24 hrs to be recruited and
activated in inflamed environment. CLP was performed always by
the same scientist who was blinded to the experimental design
until the final time point of experiment (death of mice). Sham-
treated controls underwent the same surgical procedures (i.e.
laparotomy and resuscitation), but the cecum was neither ligated
nor punctured.
Bacterial Forming Colony Analysis
Bacterial counts were performed on aseptically harvested spleens,
lungs and livers as described previously [24]. The tissues were
weighed, homogenized, and cellular debris pelleted. The super-
natant samples were serially diluted in sterile saline and cultured
on tryptic soy agar pour plates. Plates were incubated for 48 hours
after which colony counts were performed. Data are expressed as
colony counts per gram tissue.
Tissue Damage Assessment
The spleen, liver and lung were harvested from sham and CLP
mice and placed into 4% paraformaldehyde. The tissue were
sliced and stained according to standard protocols used by
American Histolabs, Gaithersburg, MD.
To estimate hepatocellular injury during sepsis, ALT serum
activity was determined as previously described [6].
Analysis of granulocyte functions in extraperitoneal
organs
Functions of granulocytes–production of hydrogen peroxide and
expression of CD11b–were determined as previously described
[2].
Isolation of mononuclear cells from spleen, lymph
nodes and peritoneum
Spleens (lymph nodes) were homogenized using a 70 mm cell
strainer. Cells from the peritoneum were collected by insertion and
withdrawing of 10 ml of sterile PBS from the peritoneal space.
Purified T cells were obtained by negative selection on
AutoMACS cell separator using the Pan T-cell isolation kit
(Miltenyi Biotech) and placed in RPMI 1640 (Biofluids) supple-
mented with 5% dialyzed FCS (heat inactivated) and 100 U/ml
penicillin, 100 mg/ml streptomycin, 1 mM sodium pyruvate,
1 mM HEPES, and non-essential amino acids (RP5). Viability
was assessed using trypan blue.
Cytokine measurements
Intracellular staining of TCR-activated cells to evaluate IFN-c
production in situ was performed in permeabilized cells (after 4 h
of anti-CD3 and anti-CD28 mAb restimulation) by flow cytometry
analysis using anti-cytokine mAB (BD Pharmingen), 2 mM (final
concentration) monensin (Cal-Biochem) and saponin buffer (PBS
containing 0,1% (w/v) saponin, 0,1% BSA, 0,01 M HEPES and
0,1% sodium azide) as described [10] Extracellular cytokine
concentrations from serum, peritoneal fluid and from cell culture
supernatant were determined by ELISA kits (BD Pharmingen)
according to the manufacturer’s instructions.
Flow cytometry
Analyses of cell surface antigen expression and of IFN-c expression
in situ were performed as described earlier [10]. Flow cytometry
data acquisition and analysis were done on LSR, DIVA and
CellQuestPro programs (Becton Dickinson). All mAb used for
cytometry were obtained from BD Pharmingen.
Ex vivo activation of T cells
Purified T-cells were cultured in 12-well plates pre-coated with
anti-CD3 and anti-CD28 mAb 3 micro g/ml each. (Culture
volume was 1 ml per well containing 36106 cells.)
Cells were cultured in normoxic (21% O2) or hypoxic (1% O2)
environments. Normoxia was controlled by using a humidified 5%
HIF-1a Inhibits T cells
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CO2/air incubator, and hypoxia by pregasing culture medium for
10 min in a sealed hypoxic work station with 5% CO2/balance N2
gas mix and subsequent culture in a humidified hypoxic (CO2/N2)
incubator. Supernatants and cells were harvested 24 h later.
Analysis of cell proliferation
Purified splenic T cells were stained using 5,6-carboxyfluorescein
diacetate succinimidyl ester (CFSE), activated by platebound 3
micro g/mL anti-CD3 and anti-CD28 mAb for 72 hours and
analyzed by flow cytometry as described [25].
NF-kB DNA binding activity
Nuclear proteins were extracted from 1,56107 T-cells using the
Active Motif Nuclear Extract kit according to the manufacturer’s
instructions, total protein concentrations of the lysates were
determined by Bradford assay (Bio-Rad). EMSA was performed
as in [26]. The DNA binding activity of the NF-kB subunits in
5 mg of T-cell nuclear extracts was quantified by an ELISA assay
using the trans-AM NF-kB family transcription factor assay kit
(Active Motif North), according to the manufacturer’s protocol.
Quantitative RT-PCR
Spleen samples were homogenized before Total RNA isolation
using the RNeasy mini kit (Qiagen) including DNAse treatment
following the manufacturer’s protocol. Equal amounts of RNA
from the different samples were transcribed into cDNA using the
Superscript first strand RT-PCR kit (Invitrogen). Real-time qPCR
was performed in duplicates with the Light Cycler480 instrument
(Roche Diagnostics) using the Roche’s SYBR-Green mastermix
and prevalidated primer pairs (Qiagen). The thermal cycler
conditions were 35 cycles of 94uC for 20 s, 55uC for 20 s, and
72uC for 30 s. Relative mRNA expression was calculated with the
Relative Quantification software (Roche Diagnostics) using an
efficiency-corrected algorithm with standard curves and 18S
ribosomal RNA as an endogenous reference.
Statistical Analysis
All data were analyzed using GraphPad Prism software (GraphPad
Software). If otherwise not stated, values given represent
means6SD. Intergroup comparisons were performed by unpaired
T-Test or Mann-Whitney Test, if data were normal or not
normally distributed, respectively. Survival curves were compared
using the Log Rank test. Two-tailed levels of statistical significance
are indicated by *:p,0.05.
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